|
AGLE | Spyre Therapeutics, Inc. |
|
|
AGLE | Spyre Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 8.54 |
| Leverage | 22.25% |
| Market Cap | $ 38.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -235.4m |
| Margin | 971.31% |